Cargando…
The role of melatonin in the treatment of type 2 diabetes mellitus and Alzheimer's disease
In type 2 diabetes mellitus (T2DM) and its related disorders like obesity, the abnormal protein processing, oxidative stress and proinflammatory cytokines will drive the activation of inflammatory pathways, leading to low-grade chronic inflammation and insulin resistance (IR) in the periphery and im...
Autores principales: | Shen, Shengnan, Liao, Qiwen, Wong, Yin Kwan, Chen, Xiao, Yang, Chuanbin, Xu, Chengchao, Sun, Jichao, Wang, Jigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771831/ https://www.ncbi.nlm.nih.gov/pubmed/35173531 http://dx.doi.org/10.7150/ijbs.66871 |
Ejemplares similares
-
Impairment of the autophagy–lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential
por: Zhang, Wei, et al.
Publicado: (2022) -
Novel Insight into Functions of Transcription Factor EB (TFEB) in Alzheimer’s Disease and Parkinson’s Disease
por: Yang, Jing, et al.
Publicado: (2023) -
Extracellular vesicles in type 2 diabetes mellitus: key roles in pathogenesis, complications, and therapy
por: Xiao, Yongwei, et al.
Publicado: (2019) -
A novel autophagy activator ginsenoside Rh2 enhances the efficacy of immunogenic chemotherapy
por: Yang, Jing, et al.
Publicado: (2023) -
Anti-Inflammatory Effects of Melatonin in Rats with Induced Type 2 Diabetes Mellitus
por: Yapislar, Hande, et al.
Publicado: (2022)